biosig_rgb.png
BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission
14 nov. 2017 08h00 HE | BioSig Technologies, Inc.
Santa Monica, CA, Nov. 14, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
biosig_rgb.png
BioSig Technologies Partners with Sherpa Technology Group
02 nov. 2017 08h00 HE | BioSig Technologies, Inc.
Santa Monica, CA, Nov. 02, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
biosig_rgb.png
BioSig Technologies Announces Results of Independent Product Assessment Study for PURE EP System
26 oct. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Oct. 26, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
biosig_rgb.png
BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization
24 oct. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Oct. 24, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
biosig_rgb.png
BioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022
19 oct. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Oct. 19, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need within...
biosig_rgb.png
BioSig Technologies to Present at the Dawson James Small Cap Growth Conference
13 oct. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Oct. 13, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
Cytta Name Logo.jpg
Telemedicine Technology Joint Venture Announced Between Cytta Corp and Cardiocomm Solutions
12 oct. 2017 07h30 HE | Cytta Corp.
Palm Desert, CA, Oct. 12, 2017 (GLOBE NEWSWIRE) -- Cytta Corp. (OTCPINK:CYCA), a leading provider of mobile smartphone and web based healthcare technology solutions, and CardioComm Solutions, Inc....
biosig_rgb.png
BioSig Technologies Welcomes Joseph W. Rafferty as Chief Commercialization Officer
11 oct. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Oct. 11, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
biosig_rgb.png
BioSig Technologies Welcomes Natasha Russkina as Managing Director, Europe
31 mai 2017 03h00 HE | BioSig Technologies, Inc.
MINNEAPOLIS, May 31, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need for...
biosig_rgb.png
PURE EP System Featured in the Journal of Innovations in Cardiac Rhythm Management
09 mai 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, May 09, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need for...